Patient-Specific Versus Conventional Instrumentation in TKA
NCT ID: NCT02002624
Last Updated: 2013-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2011-09-30
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional
Conventional instrumentation
Conventional instrumentation
PSI
Patient specific instrumentation
PSI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PSI
Conventional instrumentation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged between 18 and 85 years
* able to understand information
* affiliated to social security.
Exclusion Criteria
* tumor around the knee
* previous partial or total knee replacement
* presence of hardware that could artifact MRI
* contraindication to MRI
* extra-articular deformation requiring osteotomy around the knee in conjunction with TKA
* social situation that could impair follow-up.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cochin Hospital
AMBIG
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moussa Hamadouche
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephane Boisgard, MD, PhD
Role: STUDY_DIRECTOR
University Hospital, Clermont-Ferrand
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCP SC 2837
Identifier Type: -
Identifier Source: org_study_id